Last updated 6 days ago
A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight
1000 patients around the world
Available in United States, Mexico
Eli Lilly and Company
7Research sites
1000Patients around the world
This study is for people with
Urinary Incontinence
Requirements for the patient
From 18 Years
Female
Medical requirements
- Have a body mass index (BMI) of 27 kilograms per square meter (kg/m2) or higher at screening.Have a diagnosis of stress urinary incontinence.
- Have had urinary incontinence surgery.Have recently received onabotulinumtoxin A (Botox) bladder injections or currently taking medications for urinary incontinence.Have given birth within one year of screening.Have had a change in body weight of more than 11 pounds within 90 days prior to screening.Have used any anti-obesity medication or alternative weight loss remedies within 180 days prior to screening.Have type 1 diabetes, type 2 diabetes, or any other type of diabetes.Have had a cardiovascular health condition within 90 days prior to screening.Are pregnant, intending to be pregnant, breastfeeding, or intending to breastfeed for the duration of the study.
Sites
Centro de Oncología de Precisión
Clinstile S.A de C.V.
RM Pharma Specialists S.A. de C.V.
Medimanage Research
Medical Care & Research SA de CV - México
Health Pharma Professional Research
Centro de Investigación Clínica Chapultepec S. A. de C. V. - Morelia
StudyRESTRAIN-SUI
SponsorEli Lilly and Company
Study typeInterventional
Conditions
Urinary Incontinence
Requirements
From 18 YearsFemale
Unique study IDclinicaltrials.gov
NCT07202884
